Lataa...
Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel(®): A Case Report
The CLARINET study (ClinicalTrials.gov: NCT00353496) showed that somatostatin analogs are able to stabilize tumor growth in patients with intestinal and pancreatic neuroendocrine tumors (NETs). Here, we present a case of NET originating from the pancreatic tail that was treated with lanreotide Autog...
Tallennettuna:
| Julkaisussa: | Case Rep Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
S. Karger AG
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224256/ https://ncbi.nlm.nih.gov/pubmed/25408662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368207 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|